Focus on Receptors for Coronaviruses with Special Reference to Angiotensin- Converting Enzyme 2 as a Potential Drug Target - A Perspective

Endocr Metab Immune Disord Drug Targets. 2020;20(6):807-811. doi: 10.2174/1871530320666200427112902.
No abstract available

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / chemical synthesis
  • Angiotensin II Type 1 Receptor Blockers / chemistry
  • Angiotensin II Type 1 Receptor Blockers / isolation & purification
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme 2 / antagonists & inhibitors*
  • Angiotensin-Converting Enzyme 2 / physiology
  • Angiotensin-Converting Enzyme Inhibitors / chemical synthesis
  • Angiotensin-Converting Enzyme Inhibitors / chemistry
  • Angiotensin-Converting Enzyme Inhibitors / isolation & purification
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antiviral Agents* / chemical synthesis
  • Antiviral Agents* / chemistry
  • Antiviral Agents* / isolation & purification
  • Antiviral Agents* / therapeutic use
  • COVID-19 / drug therapy
  • COVID-19 / immunology
  • COVID-19 / virology
  • Coronavirus / drug effects*
  • Coronavirus / physiology
  • Coronavirus Infections / drug therapy*
  • Humans
  • Immunity / drug effects
  • Immunity / physiology
  • Middle East Respiratory Syndrome Coronavirus / drug effects
  • Middle East Respiratory Syndrome Coronavirus / physiology
  • Receptor, Angiotensin, Type 1 / physiology
  • Receptors, Virus* / antagonists & inhibitors
  • Receptors, Virus* / drug effects
  • Receptors, Virus* / physiology
  • Renin-Angiotensin System / drug effects
  • Renin-Angiotensin System / physiology

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antiviral Agents
  • Receptor, Angiotensin, Type 1
  • Receptors, Virus
  • Angiotensin-Converting Enzyme 2